Transitioning from Marketplace to Medicare Health Coverage for Ryan White HIV/AIDS Program Clients
Resource updated 09/25/2023
Resource updated 09/25/2023
Resource updated 10/04/2023
Blog updated 04/21/2021
Additional technical tools for data reporting for the Ryan White HIV/AIDS Program (RWHAP) have been released by the HRSA-funded technical assistance provider, DISQ (the Data Integration, Systems and Quality Team). In addition to timelines for reporting of the RSR and the EHE Initiative Triannual Module, find:
Resource updated 08/28/2023
This session reviewed functionality within CAREWare 6 for the ADAP Data Report (ADR).
Resource updated 06/27/2024
Review of the Training of Consumers for Quality Plus Program (TCQPlus), which prepares a team of training partners (staff and consumers to conduct quality improvement trainings.
Resource updated 03/14/2023
Resource updated 03/15/2023
Resource updated 02/27/2024
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
This interactive workshop will share Virginia's experiences and lessons learned from the Virginia Consumer Advisory Committee (VACAC). The workshop will provide perspective on effectively engaging consumers in ending the HIV/AIDS epidemic. The session will highlight VACAC's structure and how it interacts with consumers, the Virginia Department of Health, and service providers.
Resource (Conference Presentation) updated 09/14/2023
This session will explore the continuum of meaningful involvement among persons with HIV at the community, regional, and national levels. A panel of community stakeholders will share experiences participating in community forums, boards, and other advocacy opportunities.
Resource (Conference Presentation) updated 09/14/2023
Cuaderno de trabajo sobre cómo establecer y operar una junta asesora para los consumidores (CAB, siglas en inglés), relacionada con las operaciones de CAB para los programas dirigidos a las mujeres, bebés, niños y jóvenes de la Parte D (Título IV).
Resource updated 09/19/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023
Rapid initiation of antiretroviral therapy (ART) after diagnosis can increase the number of patients arriving for appointments, shorten time to viral suppression, and promote health equity. The presenters share key lessons learned through the implementation process at a large HIV clinic in the South with the theme of partnerships.
Resource (Conference Presentation) updated 09/14/2023
In December 2016 CrescentCare began linking individuals newly diagnosed with within 72-hours through the CrescentCare START Initiative. We compared linkage and viral suppression between those under and over 24 years old. We found similar successful outcomes for both age cohorts in our intervention.
Resource (Conference Presentation) updated 09/14/2023